Literature DB >> 7126410

The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

K Wilson, M Oram, C E Horth, D Burnett.   

Abstract

1 The rate of methaqualone metabolism in women was shown to be significantly increased at the time of ovulation. 2 The apparent first order rate constants for the formation of five C-monohydroxy metabolites of methaqualone on day 15 of the menstrual cycle were approximately double that on day 1. 3 The N-oxidation of methaqualone showed considerable inter-individual variation in its sensitivity to the menstrual cycle, and in a group of ten women the difference in N-oxide excretion between days 1 and 15 was not statistically significant. 4 The serum clearance of methaqualone on day 15 was higher (mean value 94.6 ml min-1 on day 1, 176.0 ml min-1 on day 15), serum half-life shorter (mean t1/2 beta 16.3 h on day 1, 11.6 h on day 15) and the AUC alpha smaller (mean value 44.0 micrograms ml-1 h on day 1, 24.4 micrograms ml-1 h on day 15) than on day 1. 5 The relative importance of the five hydroxy metabolites was unchanged during the menstrual cycle but the C/N oxidation ratio was greater on day 15 than on day 1. 6 The data for methaqualone metabolism in a control group of men was similar to than in women on day 1 of a menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126410      PMCID: PMC1427643          DOI: 10.1111/j.1365-2125.1982.tb01988.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  23 in total

1.  Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes.

Authors:  G Kellermann; M Luyten-Kellermann; M G Horning; M Stafford
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

2.  Urinary excretion of c-hydroxy derivatives of methaqualone in man.

Authors:  D Burnett; C N Reynolds; K Wilson; J R Francis
Journal:  Xenobiotica       Date:  1976-02       Impact factor: 1.908

3.  Environmental effects on antipyrine half-life in man.

Authors:  H S Fraser; J C Mucklow; C J Bulpitt; C Khan; G Mould; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

4.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

5.  Plasma kinetics of methaqualone in man after single oral doses.

Authors:  G Alván; J E Lindgren; C Bogentoft; O Ericsson
Journal:  Eur J Clin Pharmacol       Date:  1973-10       Impact factor: 2.953

6.  Microsomal flavoprotein-catalyzed N-oxidation of arylamines.

Authors:  D M Ziegler; E M McKee; L L Poulsen
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

7.  A comparison of the inductive effects of phenobarbital, methaqualone, and methyprylon on hepatic mixed function oxidase enzymes in the rat.

Authors:  L A Reinke; M F O'Connor; R W Piepho; S J Stohs
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-05

8.  Methaqualone metabolism by rat liver microsomes.

Authors:  P Manowitz; C M Shull
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-01

9.  Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans.

Authors:  R Herz; H R Koelz; U P Haemmerli; I Benes; A L Blum
Journal:  Eur J Clin Invest       Date:  1978-02       Impact factor: 4.686

10.  Effect of age and sex on human drug metabolism.

Authors:  K O'Malley; J Crooks; E Duke; I H Stevenson
Journal:  Br Med J       Date:  1971-09-11
View more
  7 in total

1.  Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Authors:  B Bruguerolle; M Toumi; F Faraj; D Vervloet; H Razzouk
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers.

Authors:  V K Nayak; N A Kshirsagar; N K Desai; R S Satoskar
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

3.  Salivary paracetamol elimination kinetics during the menstrual cycle.

Authors:  L Somaja; J Thangam
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

Review 4.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 5.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  The effect of age on the competitive C- and N-oxidative pathways of methaqualone in women.

Authors:  K Wilson; M Oram; D Burnett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

7.  The influence of oral contraceptives on the metabolism of methaqualone in man.

Authors:  M Oram; K Wilson; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.